Clinical profile of neurological manifestations and CD4 counts in patient living with HIV cases and its outcome with treatment with ART at a tertiary hospital

 

Sanjay B Jagtap^1*, Pooja M Patil²

 

REFERENCES

1. UNAIDS: GLOBAL HIV and AIDS FACTSHEET 2020. Available at: https://www.unaids.org/en/resources/fact-sheet Accessed on 3rd Nov 2020.
2. WHO Factsheet 2019. HIV/AIDS in the South-East Asia Available at: https://www.who.int/southeastasia/health-topics/hiv-aids Accessed on 3rd Nov 2020
3. Rosenblum ML, Levy RM, Bredesen DE. AIDS and The Nervous System. New York: Raven Press, 1988.Resnick L, Berger JR, Shapshak P, Tourtellotte WW. Early penetration of theblood-brain-barrier by HIV. Neurology. 1988 Jan;38(1):9-14.
4. Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSFand review of the literature. J Neurosurg. 1985;62:475-495.
5. Fauci AS, Fellkers GK, Lane C. Ch.197: HIV Disease; AIDS and Related disorders. In: Harrisons principle of internal medicine, Braunward E; et al. NewYork, Mc-Graw Hill, 20th Edition. 2019; 1391-1397.
6. Burdo T H, Soulasc, J Krishna A, Sugimoto et al. Increased monocyte turnover From bone marrow correlates with severity of HIV encephalitis.PLoS.patho, 2010;6(4):e 100842.
7. HIV Sentinel Surveillance and HIV Estimation in India 2016. A Technical Brief. Available at: http://naco.gov.in/surveillance-epidemiology-0 Accessed on 3rd Nov 2020.
8. National AIDS Control Organization. ART treatment. 2016. Available at: http://www.naco.gov.in/treatment Accessed on 19th Feb 2021
9. Singer EJ, Valdes-Sueiras M, Commins D, Levine A. Neurologic presentations of AIDS. Neurol Clin. 2010;28(1):253-275. doi:10.1016/j.ncl.2009.09.018
10. Sharma SR, Hussain M, Habung H. Neurological manifestations of HIV-AIDS Neurology India 2017; 65(1):357-61.
11. Wiley CA, Schrier RD, Nelson JA, et al. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proceedings of the National Academy of Sciences of the United States of America. 1986;83:7089–7093.
12. Bolokadze N, Gabunia P, Ezugbaia M, Gatserelia L, Khechiashvili G. Neurological complications in patients with HIV/AIDS. Georgian Med News 2008; 165:34-8.
13. Devulapally N, Pandharpurkar D, B. Gouthami, Gudikandula K. A Clinical Study on Opportunistic Infections among HIV/AIDS Patients Admitted in the Department of General Medicine of a Tertiary Care Hospital. Int J contemporary Medical Research. 2019;6(4): D4-8
14. Mir M A, Ahmad P M, Siddeque M A, Sofi F A, Ahmad S N, Da M R. Clinical and demographic profile of HIV/AIDS patients diagnosed at a tertiary care centre in Kashmir. J Pak Med Assoc 2010; 60(6):428- 31
15. CDC. Diagnoses of HIV infection in the United States and dependent areas, 2018 (updated). HIV Surveillance Report 2020;31.
16. Badave RR and Basavaraj A. Clinical Profile of Cryptococcal Meningitis in Patients Living with HIV Infection: An Experience from Western India. Medical Journal of Dr. D.Y. Patil Vidyapeeth January-February 2018;11:(1):30-32.
17. Kumar D, Bishnoi S, Meena DS, Bohra GK, Midha N, Chhabra V, Bhambu SK. Evaluation of Clinical Profile, Diagnostic Tests, And Prognosis of Cryptococcal Meningitis in HIV Infected Patients in Western India. Infect Disord Drug Targets. 2020 May 16.
18. Luma H N, Nguenkam Tchaleu B C, Temfack E, et al. "HIV-Associated Central Nervous System Disease in Patients Admitted at the Douala General Hospital between 2004 and 2009:A Retrospective Study", AIDS Research and Treatment, vol. 2013, ArticleID 709810, 6 pages, 2013.
19. Lakshmi V, Sudha T, Teja VD, Umabala P. Prevalence of central nervous system cryptococcosis in human immunodeficiency virus reactive hospitalized patients. Indian J Med Microbiol 2007; 25:146-9.
20. Kumar S, Wanchu A, Chakrabarti A, Sharma A, Bambery P, Singh S, et al. Cryptococcal meningitis in HIV infected: Experience from a North Indian tertiary center. Neurol India 2008;56: 444-49.
21. Prasad KN, Agarwal J, Nag VL, Verma AK, Dixit AK, Ayyagari A, et al. Cryptococcal infection in patients with clinically diagnosed meningitis in a tertiary care center. Neurol India 2003; 51:364-6.
22. Perello R, Vergara A, Monclus E, et al. Cytomegalovirus infection in HIV- infected patients in the era of combination antiretroviral therapy. BMC Infect Dis. 2019;19(1):1030. Published 2019 Dec 4. doi:10.1186/s12879-019-4643-6
23. Price RW. Neurological complications of HIV infection. Lancet 1996; 348:445.
24. Kapila K, Sharma YV, Kotwal J, Banerjee A, Kaur J. Cryptococcal meningitis: A Clinicopathological account of seven cases encountered in a military setting. Med J Armed Forces India 2003; 59:189-93.
25. Abhilash KP, Mitra S, Arul JJ, Raj PM, Balaji V, Kannangai R, et al. Changing paradigm of cryptococcal meningitis: An eight-year experience from a tertiary hospital in South India. Indian J Med Microbiol 2015; 33:25-9.
26. Jha P, Kumar R, Khera A, Bhattacharya M, Arora P, Gajalakshmi V. HIV mortality and infection in India: estimates from nationally representative mortality survey of 1.1 million homes. BMJ. 2010; 340: c621.
27. Javalkar P, Prakash R, Issac S, Washington R and Halli SS. An Estimation of Mortality Risks among People Living with HIV in Karnataka State, India: Learnings from an Intensive HIV/AIDS Care and Support Programme Available at:https://journals.plos.org/plosone/article?id=10.1371/journal.pone.015661 1 Accessed on 12th Feb 2021.
28. Ghate M, Deshpande S, Tripathy S, Nene M, Gedam P, Godbole S. Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD4 counts. 2009; 13(1):e1-e8.
29. Singh A, Bairy I, Shivananda PG. Spectrum of opportunistic infections in AIDS cases. Indian J Med Sci 2003;57:16—21.
30. Staszewski S, Miller V, Sabin C, Schlecht C, Gute P, Stamm S, et al. Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy. AIDS 1999;13:951-6.
31. Hunt PW, Deeks SG, Rodriguez B, Valdez H, Shade SB, Abrams DI, et al. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS 2003; 17:1907-15.
32. Kaufmann GR, Bloch M, Finlayson R, Zaunders J, Smith D, Cooper DA. The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy. AIDS 2002; 16:359- 67.